CME vs NDAQ
CME Group and Nasdaq, Inc., both Financial Services
CME Group is the larger company at $89B against $47B. On trailing earnings CME is the cheaper of the two at a P/E of 23.8 against 29.0, a gap that is only a bargain if the two are growing at similar rates. Over the past year NDAQ returned +4.3% against +3.8% for CME. Ryufin's sector-relative Smart Score puts CME ahead, 7/10 against 4/10.
| Figure | CME | NDAQ |
|---|---|---|
| Last close | $281 | $99.45 |
| Market cap | $89B | $47B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 23.8 | 29.0 |
| Dividend yield | 1.8% | 1.1% |
| 1-year return | +3.8% | +4.3% |
| 5-year return | +63% | +71% |
| Ryufin Smart Scoresector-relative, 1–10 | 7/10 | 4/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
CME Group
Revenue of $1.7B in Q2 2026, net income $1.0B. Its largest reported line is Clearingandtransactionfees, 79% of the disclosed total.
Nasdaq, Inc.
Revenue of $2.5B in Q2 2026, net income $507M. Its largest reported line is Market Services, 49% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.